474010-69-0Relevant academic research and scientific papers
Inhibitors of HIV-1 attachment. Part 11: The discovery and structure-activity relationships associated with 4,6-diazaindole cores
Bender, John A.,Yang, Zhong,Eggers, Betsy,Gong, Yi-Fei,Lin, Pin-Fang,Parker, Dawn D.,Rahematpura, Sandhya,Zheng, Ming,Meanwell, Nicholas A.,Kadow, John F.
, p. 218 - 222 (2013/02/23)
A series of HIV-1 attachment inhibitors containing a 4,6-diazaindole core were examined in an effort to identify a compound which improved upon the potency and oral exposure of BMS-488043 (2). BMS-488043 (2) is a 6-azaindole-based HIV-1 attachment inhibit
Benzothiazole antiviral agents
-
Page/Page column 10, (2008/06/13)
The invention encompasses a series of benzothiazole compounds which inhibit HIV entry and are useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for using these compounds.
Bicyclo 4.4.0 antiviral derivatives
-
Page/Page column 29; 32, (2008/06/13)
This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with amido piperazine derivatives. These compounds possess unique antiviral activity
Indole, azaindole and related heterocyclic amidopiperazine derivatives
-
, (2008/06/13)
This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with amido piperazine derivatives. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS.
